Multi-System Integration and Synthesis

The energy-immune-autonomic triad represents a core integrative framework for ME/CFS. Energy metabolism impairment (Chapter 6) reduces ATP available for immune function and autonomic regulation. Immune activation (Chapter 7) both consumes metabolic resources and disrupts autonomic signaling. Autonomic dysfunction (Chapters 8–10) impairs cerebral blood flow and gut motility, further compromising metabolic and immune function. These three systems form a self-reinforcing cycle where dysfunction in one domain amplifies dysfunction in others.

Clinical evidence for integration: The NIH deep phenotyping study (Walitt et al., 2024) identified coordinated abnormalities across these three domains in the same patients. Two-day CPET studies demonstrate functional consequence: reduced work capacity that fails to recover fully after 24 hours, consistent with multi-system impairment rather than isolated muscular defect.

Cross-disease integrative perspective: The comparative nosology framework (see Comparative Nosology: ME/CFS Among Contested Diagnoses, Three Axes for Classifying the Contested Diagnosis Cluster) proposes that PEM status, rather than diagnostic label, is the critical variable for classifying patients across the contested-diagnosis cluster. This integrative model extends the energy-immune-autonomic triad by adding a cross-disease dimension: the same triadic dysfunction may underlie ME/CFS, Long COVID, fibromyalgia, and PTLDS, with PEM status determining which patients respond similarly to exercise-based interventions regardless of which diagnosis they carry.